VERA PDUFA date: FDA decision expected November 30, 2026

The FDA is expected to decide on this application from Vera Therapeutics, Inc. by the PDUFA target action date of November 30, 2026. Extracted from: Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals

A PDUFA date is the FDA's target deadline to complete its review of a drug application — approval, a complete response letter (CRL), or an extension are all possible. What is a PDUFA date? This page is research information, not financial advice.